Contact Dermatitis

  • Katyrena Kiselova
  • John J. RussellEmail author
Part of the Current Clinical Practice book series (CCP)


Contact dermatitis is a common condition seen in primary care. It makes up 10–20% of dermatologic conditions. It can affect all professions, although some professionals are at higher risk. The condition develops secondary to an irritant or allergens. Irritants make up a larger portion of these two causes. Diagnosis is often clinical although some patients may require further testing to identify the offending agent. Treatment is usually topical steroids, and prevention by avoidance is a mainstay to prevent exacerbations.


Contact dermatitis Hand dermatitis Toxicodendron dermatitis Topical corticosteroids Patch testing 


  1. 1.
    Martin S. Contact dermatitis: from pathomechanisms to immunotoxicology. Exp Dermatol. 2012;21(5):382–9.PubMedCrossRefGoogle Scholar
  2. 2.
    Rashid RS, Shim TN. Contact dermatitis. BMJ. 2016;353:i3299.PubMedCrossRefGoogle Scholar
  3. 3.
    Proksch E, Brasch J. Abnormal epidermal barrier in the pathogenesis of contact dermatitis. Clin Dermatol. 2012;30(3):335–44.PubMedCrossRefGoogle Scholar
  4. 4.
    Mowad C, et al. Allergic contact dermatitis. J Am Acad Dermatol. 2016;74(6):1029–40.PubMedCrossRefGoogle Scholar
  5. 5.
    Wiszniewska M, Walusiak-Skorupa J. Recent trends in occupational contact dermatitis. Curr Allergy Asthma Rep. 2015;15(7):43.PubMedCrossRefGoogle Scholar
  6. 6.
    Laguna C, et al. Allergic contact dermatitis due to cosmetics: a clinical and epidemiological study in a tertiary hospital. Actas Dermosifiliogr. 2009;100(1):53–60.PubMedCrossRefGoogle Scholar
  7. 7.
    Lee JY, Effendy I, Maibach HI. Acute irritant contact dermatitis: recovery time in man. Contact Dermatitis. 1997;36:285–90.PubMedCrossRefGoogle Scholar
  8. 8.
    Choi JM, Lee JY, Cho BK. Chronic irritant contact dermatitis: recovery time in man. Contact Dermatitis. 2000;42(5):264–9.PubMedCrossRefGoogle Scholar
  9. 9.
    Curtis G, Lewis AC. Treatment of severe poison ivy: a randomized, controlled trial of long versus short course oral prednisone. J Clin Med Res. 2014;6(6):429–34. PMC. Web. 1 Sept. 2016.PubMedPubMedCentralGoogle Scholar
  10. 10.
    Lee NP, Arriola ER. Poison ivy, oak, and sumac dermatitis. West J Med. 1999;171.5-6:354–355. Print.Google Scholar
  11. 11.
    Kranke B, Schuster C. Contact dermatitis: relevant differential diagnoses, simulators and variants. J Dtsch Dermatol Ges. 2015;13:1073.PubMedGoogle Scholar
  12. 12.
    Mowad C. Contact dermatitis: practice gaps and challenges. Dermatol Clin. 2016;34:263–7.PubMedCrossRefGoogle Scholar
  13. 13.
    Welsh E, Goldenberg A, Welsh O, Jacob SE. Contact dermatitis: therapeutics when avoidance fails. J Allergy Ther. 2014;5:185.CrossRefGoogle Scholar
  14. 14.
    Draelos Z. New treatments for restoring impaired epidermal barrier permeability: skin barrier repair creams. Clin Dermatol. 2012;30:345–8.PubMedCrossRefGoogle Scholar
  15. 15.
    Mostosi C, Simonart T. Effectiveness of barrier creams against irritant contact dermatitis. Dermatology. 2016;232:353–62.PubMedCrossRefGoogle Scholar
  16. 16.
    American Academy of Allergy, Asthma and Immunology; American College of Allergy, Asthma and Immunology. Contact dermatitis: a practice parameter. Ann Allergy Asthma Immunol. 2006;97(3 suppl 2):S1–S38.Google Scholar

Copyright information

© Springer Nature Switzerland AG 2019

Authors and Affiliations

  1. 1.Department of Family MedicineAbington-Jefferson HealthAbingtonUSA
  2. 2.Family Medicine Residency ProgramAbington Hospital-Jefferson HealthJenkintownUSA

Personalised recommendations